BOLT BIOTHERAPEUTICS INC (BOLT) Earnings History & Surprises

NASDAQ:BOLTUS0977022039

Current stock price

4.28 USD
-0.1 (-2.28%)
Last:

BOLT Earnings overview

Past quarterly earnings results for BOLT BIOTHERAPEUTICS INC (BOLT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$4.29
Revenue Estimate
969K

Last Reported

Most Recent
Release Date
Mar 12, 2026
Period
Q4 / 2025
EPS Reported
-$3.84
EPS Surprise
38.35%
Revenue Surprise
267.65%

Beat Rate

Last 8 Quarters
81%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -3.84 -6.23 38.35% 49.47% 2.5M 680.003K 267.65% -
Q3 2025 -3.72 -5.90 36.99% 53.50% 2.169M 739.5K 193.31% 90.10%
Q2 2025 -4.46 -6.58 32.21% 51.52% 1.804M 836.145K 115.75% 41.49%
Q1 2025 -5.80 -7.40 21.57% -3.57% 1.222M 782.85K 56.10% -76.83%
Q4 2024 -7.60 -7.75 1.96% 19.15% 805.8K -100.00% -100.00%
Q3 2024 -8.00 -7.19 -11.25% 6.98% 1.141M 1.288M -11.41% -54.87%
Q2 2024 -9.20 -9.79 6.05% 4.17% 1.275M 909.33K 40.21% -11.03%
Q1 2024 -5.60 -10.40 46.17% 37.78% 5.274M 2.105M 150.55% 188.83%
Q4 2023 -9.40 -9.83 4.34% 11.32% 2.089M 1.747M 19.58% 48.16%
Q3 2023 -8.60 -10.20 15.69% 25.86% 2.528M 1.76M 43.64% 19.81%
Q2 2023 -9.60 -9.93 3.30% 21.31% 1.433M 1.939M -26.10% 3.09%
Q1 2023 -9.00 -10.44 13.78% 29.69% 1.826M 1.332M 37.09% 125.43%
Q4 2022 -10.60 -12.21 13.16% 27.40% 1.41M 1.254M 12.44% 176.47%
Q3 2022 -11.60 -11.49 -0.94% 7.94% 2.11M 1.004M 110.16% 181.33%
Q2 2022 -12.20 -13.82 11.73% 4.69% 1.39M 382.5K 263.40% -
Q1 2022 -12.80 -14.64 12.55% 43.86% 810K 382.5K 111.76% -
Q4 2021 -14.60 -16.69 12.51% 94.99% 510K 382.5K 33.33% -
Q3 2021 -12.60 -13.31 5.34% - 750K 382.5K 96.08% -
Q2 2021 -12.80 -8.77 -45.92% - 3.4M -100.00% -100.00%
Q1 2021 -22.80 -12.24 -86.27% - - -100.00%
Q4 2020 -291.60 -36.77 -693.02% - 51K -100.00% -
Q3 2020 - - - -
Q2 2020 - - 70K - -
Q1 2020 - - 160K - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

BOLT EPS Q2Q GrowthBOLT EPS Q2Q GrowthEPS Q2Q Growth Q4/21 Q2/22 Q4/22 Q2/23 Q4/23 Q2/24 Q4/24 Q2/25 Q4/25 Q2/26 Q4/26 0 20 40 60 80

Revenue Historical Q2Q growth and Acceleration

BOLT Revenue Q2Q GrowthBOLT Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q2/26 Q4/26 0 50 -50 100 150

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
4
Average EPS beat (4)
32.28%
Max EPS beat (4)
38.35%
Min EPS beat (4)
21.57%

Revenue beat statistics

Revenue beat (4)
4
Average Revenue beat (4)
158.20%
Max Revenue beat (4)
267.65%
Min Revenue beat (4)
56.10%

Analysis

In the last 4 quarters, BOLT has consistently beaten EPS estimates in all releases
BOLT has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, BOLT has beaten the EPS estimates by 32.3% on average.
In the last 4 quarters, BOLT has beaten the revenue estimates by 158.2% on average.

BOLT BIOTHERAPEUTICS INC / BOLT Earnings FAQ

When did BOLT BIOTHERAPEUTICS INC (BOLT) report earnings last quarter?

BOLT BIOTHERAPEUTICS INC (BOLT) last reported earnings on 3/12/2026.

Can you provide information on whether BOLT BIOTHERAPEUTICS INC beat earnings estimates in the last quarter?

BOLT BIOTHERAPEUTICS INC (BOLT) beat EPS estimates and beat revenue estimates in the most recent quarter.

What percentage of the time does BOLT stock beat earnings estimates?

In the last 4 quarters, BOLT BIOTHERAPEUTICS INC (BOLT) has beaten EPS estimates in 4 out of 4 releases.